Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
Excision BioTherapeutics
company
About
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
- 11 - 50
Details
- Last Funding Type
- Seed
- Last Funding Money Raised
- $10M
- Industries
- Biotechnology,Health Care,Therapeutics
- Founded date
- Jan 1, 2015
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Excision BioTherapeutics is a private company focused on developing advanced gene-editing therapeutics to address the medical need for the treatment of life-threatening diseases caused by viral infections. They develop gene-editing medicines that eradicate or disrupt viral genes in human patients. Their mission is to advance gene-editing therapeutics for our indications into safe and efficacious medicines that will greatly improve the lives of infected individuals around the world.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
4
$70.75M
Excision BioTherapeutics has raised a total of
$70.75M
in funding over 2 rounds. Their latest funding was raised on
Feb 17, 2021 from a Series Unknown round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Feb 17, 2021 | Series Unknown | $60M | 1 | — | — | Detail |
| Feb 2, 2021 | Series A | — | 2 | — | — | Detail |
| Dec 20, 2019 | Series Unknown | $750K | 1 | — | — | Detail |
| Sep 6, 2017 | Seed | $10M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
3
Excision BioTherapeutics is funded by 3 investors.
Norwest Venture Partners
and ARCH Venture Partners
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Norwest Venture Partners
|
— | Series Unknown |
ARCH Venture Partners
|
— | Series A |
Gaingels
|
— | Series Unknown |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
